The share price response after the resource upgrades points to the market not valuing the magnetite.
From the scoping study, production is now set to start late 2014 which is disappointing. Still a long way off.
- Forums
- ASX - By Stock
- andrews letter
The share price response after the resource upgrades points to...
Featured News
Add MDX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $81.95M |
Open | High | Low | Value | Volume |
3.8¢ | 4.2¢ | 3.8¢ | $19.64K | 489.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 103983 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.030 |
1 | 200000 | 0.010 |
1 | 288888 | 0.004 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 103983 | 2 |
0.053 | 100000 | 1 |
0.056 | 50000 | 1 |
0.066 | 200000 | 1 |
0.070 | 8500 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MDX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online